Report overview
This report contains market size and forecasts of Chronic Urticaria Or Hives Drug in global, including the following market information:
Global Chronic Urticaria Or Hives Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Urticaria Or Hives Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Chronic Urticaria Or Hives Drug companies in 2021 (%)
The global Chronic Urticaria Or Hives Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GDC-0853 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Urticaria Or Hives Drug include AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited and Merck & Co., Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Urticaria Or Hives Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Urticaria Or Hives Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Type, 2021 (%)
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Global Chronic Urticaria Or Hives Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Chronic Urticaria Or Hives Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Urticaria Or Hives Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Urticaria Or Hives Drug revenues share in global market, 2021 (%)
Key companies Chronic Urticaria Or Hives Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Chronic Urticaria Or Hives Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
